PHARMACOLOGICAL REVIEW OF CHEMICALS USED FOR THE CAPTURE OF ANIMALS by Savarie, Peter J.
University of Nebraska - Lincoln 
DigitalCommons@University of Nebraska - Lincoln 
Proceedings of the 7th Vertebrate Pest 
Conference (1976) 
Vertebrate Pest Conference Proceedings 
collection 
March 1976 
PHARMACOLOGICAL REVIEW OF CHEMICALS USED FOR THE 
CAPTURE OF ANIMALS 
Peter J. Savarie 
U.S. Fish and Wildlife Service 
Follow this and additional works at: https://digitalcommons.unl.edu/vpc7 
 Part of the Environmental Health and Protection Commons 
Savarie, Peter J., "PHARMACOLOGICAL REVIEW OF CHEMICALS USED FOR THE CAPTURE OF ANIMALS" 
(1976). Proceedings of the 7th Vertebrate Pest Conference (1976). 41. 
https://digitalcommons.unl.edu/vpc7/41 
This Article is brought to you for free and open access by the Vertebrate Pest Conference Proceedings collection at 
DigitalCommons@University of Nebraska - Lincoln. It has been accepted for inclusion in Proceedings of the 7th 
Vertebrate Pest Conference (1976) by an authorized administrator of DigitalCommons@University of Nebraska - 
Lincoln. 
PHARMACOLOGICAL REVIEW OF CHEMICALS USED FOR THE CAPTURE OF ANIMALS* 
PETEIR J. SAVARIE, U.S. Fish and Wildlife Service, Building 16, Federal Center, Denver, Colorado 80225 
ABSTRACT:  A review of the l i t e r a t u r e  reveals that over 60 chemicals have been used for the 
capture of w i l d  animals, but only 30 of the most w i d e l y  used chemicals are discussed in the 
present paper.  For practical considerations these chemicals can be c l a s s i f i e d  as b e i n g  
e i t h e r  (l) neuromuscular blocking agents, or (2) central nervous system (CNS) depressants.  
Some common neuromuscular b l o c k i n g  agents are d-tubocurarine, gallamine, succiny1choline, and 
nicotine.  M99 and i t s  derivatives, phencyclidine, and xylazine are some of the more 
commonly used CNS depressants.  Neuromuscular blocking agents have a r e l a t i v e l y  r a p i d  
onset and short duration of action but they do not possess sedative, analgesic, or anesthetic 
properties.  CNS depressants do produce desirable sedative, analgesic, and anesthetic 
effects, and frequently a combination of CNS depressants results in more desirable 
immobilization characteristics. 
INTRODUCTION 
It is beyond the scope of this paper to give a comprehensive review of the pharmacology of 
all chemicals used for the capture of animals.  Only the more widely used chemicals are 
presented and discussions on the sites and mechanisms by which these chemicals manifest their 
effects have not been stressed.  The textbook by Goodman and Gilman (1975) gives a thorough 
pharmacological evaluation for most of the chemicals.  Harthoorn (1965) discusses application 
of chemicals in wildlife management programs, and an annotated bibliography, with 150 
references, summarizes the use of chemicals to immobilize mammals (Denny and Gill, 1970).  
Although the present paper primarily emphasizes chemicals to capture mammals, the reader 
interested in avian species is referred to the publication by Schafer and Cunningham (1972). 
Before 1960, neuromuscular blocking agents were the chemicals most commonly used. 
Generally speaking, the neuromuscular blocking agents are potent in many animals but they have 
less desirable immobilizing characteristics than the central nervous system depressants that 
were developed in the 1960's. 
NEUROMUSCULAR BLOCKING AGENTS 
The neuromuscular junction is a specialized anatomical area where a nerve fiber supplies a 
skeletal muscle fiber.  At this junction, a nerve impulse liberates acetylcholine from the nerve 
terminal.  Acetylcholine combines with receptor substances in the muscle membrane to initiate a 
chain of electrical events which lead to muscle contraction (Ganong, 1963).  The mechanism of 
action of drugs at the neuromuscular junction is described as being either (a) competitive or 
nondepolarizing, or (b) depolarizing.  Competitive or nondepolarizing neuromuscular blocking 
agents prevent acetylcholine from coming in contact with the receptor sites in the muscle 
membrane.  Without the availability of acetylcholine, skeletal muscle contractions cease to 
function.  Depolarizing blocking agents act like acetylcholine and produce a persistent 
depolarization at the neuromuscular junction. Initially, depolarizing blocking agents produce 
visible muscle fasciculations throughout the body before paralysis develops. In contrast, 
competitive blocking agents do not produce this effect. 
Competitive or Nondepolarizing Agents  
 d-Tubocurarine
Centuries before the use of chemicals in wildlife management programs, Indians of South 
America used poisoned arrows to kill animals for food.  The poison was called curare which is a 
generic term that applies to many poisonous plant extracts.  Curare is obtained from species of 
Strychnos and Chondodedron and crude preparations contain several closely related chemicals 
that have similar pharmacological effects (Mclntyre, 1972).  One of the active ingredients in 
curare is d-tubocurarine which has been structurally identified 
*Use of trade names in this publication does not imply endorsement of commercial products by 
the Federal Government. 
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(Everett et al., 1970). Although d-tubocurarine has not been used extensively to capture 
animals in recent times, some aspects of its pharmacology w i l l  be discussed because it 
serves as the prototype by which other neuromuscular blocking agents are evaluated. 
There is a sequential characteristic order of f la c c id  muscle paralysis in animals 
poisoned by d-tubocurarine and other competitive blocking agents (Koelle, 1975).  S m a l l,  
short, r a p i d l y  moving muscles of the eyes, ears, toes and fingers are affected first. Muscles 
of the l i m b s ,  neck, and trunk then become paralyzed.  Next, the intercostal muscles and 
f i n a l l y  the diaphragm become affected.  Death is caused by peripheral respiratory p a r al y si s  
and m i l d  terminal asphyxial convulsions may occur.  In doses that produce complete muscle 
paralysis, d-tubocurarine does not have any s i g n i f i c a n t  central nervous system stimulant, 
depressant, or analgesic effects (Smith et_al_., 1947). d-tubocurarine causes the release of 
histamine which results in hypotension, bronchospasm, and excessive s a l i v a r y  and bronchial 
secretions. 
Gallamine Triethiodide
Gallamine triethiodide is a synthetic chemical that acts in a manner s i m i l a r  to d-
tubocurarine at the neuromuscular junction.  There are fewer side effects w i t h  a paralyzing 
dose of gall amine than w i t h  a paralyzing dose of d-tubocurarine (Mushin et_al., 1949). Gallamine 
does not produce gangli o n i c  blockade nor hypotension. Its duration of action is reported to 
be shorter than that of d-tubocurarine (Post, 1959). 
Depolarizing Agents  
 Succinylcholine
Succiny1choline is an important blocking agent of the depolarizing type and has been 
widely used for the capture of w i l d  animals.  It is a synthetic chemical and may be described 
as consisting of two molecules of acetylcholine l i n k e d  together.  One advantage of 
succiny1choline is a r a p i d  onset of action and short duration.  However, there is no 
effective antidote and there is a narrow safety margin between doses that produce i m m o b i l i z a -
tion and those that produce respiratory paralysis. 
The short duration of action of succinylcholine is due to its r a p i d  metabolism by 
pseudocholinesterase found in the l i v e r  and plasma.  The i n i t i a l  metabolic product, 
succinylmonocholine, is further metabolized to succinic a c i d  and choline.  Succinyl-
monocholine has a weak neuromuscular blocking action.  Succinylmonocholine, s u c c i nic  acid, 
and choline can decrease the rate of destruction of succiny1choline by pseudocholinesterase. 
Genetic factors, l i v e r  damage or changes in n u t r i t i o n a l  states may reduce the synthesis of 
pseudocholinesterase.  Under these conditions, the action of succinylcholine may be prolonged 
(Chagas et_ al_., 1972). 
Nicotine
From a pharmacological standpoint nicotine is classified as a ganglionic s t i m u l a t i n g  
agent (Voile and Koelle, 1975), but in the doses employed for the capture of w i l d  a n i m a l s  it 
causes neuromuscular blockade which produces a cataleptoid ("waxy r i g i d i t y "  of the muscles) or 
flaccid state of muscular paralysis.  It first stimulates, and at higher doses blocks the 
action of autonomic ganglia.  As a result of t h i s  dual action, nicotine has varied and 
widespread effects in the body.  Major side effects include salivation, nausea, emesis, 
disturbed v i s i o n  and hearing, and mental confusion.  Its action on the central nervous system 
results in tremors and convulsions.  Death results from respiratory f a i l u r e  due to both 
central nervous system and respiratory muscle paralysis. 
In 14 species of a n i m a l s  tested intramuscularly, the safety factor between effective and 
lethal doses ranged from 1.5 (rat and monkey) to 3.3 (dog) (Feurt et al_., 1958). Transitory 
excitement preceded muscular paralysis in w h i t e - t a i l e d  deer (0docoileus virginianus) and the 
animals became immobilized in 2.5 to 15 minutes after receiving 200-300 mg nicotine salicylate 
intrasmuscularly (Crockford et_ al_., 1957). Recovery time ranged from 15 to 60 minutes. 
CENTRAL NERVOUS SYSTEM DEPRESSANTS 
Central nervous system (CNS) depressants can produce effective sedative, analgesic, 
narcotic, and anesthetic properties which are h i g h l y  d e s i r a b l e  characteristics for the 
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capture, restraint, and treatment of animals. These chemicals can produce signs and symptoms   
ranging from "taming" behavior to psychomotor stimulation and convulsions, sometimes within a 
single species.  A particular effect depends upon the chemical, dose, and species of animal. In   
general, the CNS depressants are safer to use than the neuromuscular blocking agents because:  
(1) they exhibit a greater safety margin, and (2) many of the CNS depressants have effective 
antidotes that reverse the immobilized condition within a matter of minutes. 
Site and mode of action of the CNS depressants are extremely complex.  The majority of CNS   
depressants can be more conveniently classified according to chemical class, rather than by mode     
of action as is true of the neuromuscular blocking agents. 
Barbiturates 
A wide range of desirable applications including sedation, hypnosis, anticonvulsant 
activity, and anesthesia can be obtained from chemicals known as barbiturates.  Barbiturates 
reversibly depress many cellular functions and are known as general depressants.  They depress   
the activity of cardiac, smooth, and skeletal muscles, nerves, and the brain. Experimental   
evidence indicates that the reticular activating system located in the brain stem is a primary 
site of action of barbiturates (Rosner and Clark, 1973). The cause of death in acute barbiturate 
poisoning is cessation of respiration.  Barbiturates have a curare-like effect at the 
neuromuscular junction and can enhance the neuromuscular blocking effects of d-tubocurarine 
(Thesleff, 1956). 
Barbiturates alone are not considered to be effective intramuscular immobilizing agents  
because of prolonged induction times (up to  1-1/2  hours). Intramuscular injections of 
thiopental of up to 200 mg/kg in northern fur seals (Callorhinus ursinus) produced only slight 
ataxia after 30 minutes (Peterson, 1965).  Thiopental, hexobarbital, and pento-barbital produced 
anesthesia within 5 minutes when administered intravenously to white-tailed deer (Severinghous,   
1950; Piperno, 1965).  Intraperitoneal injections of pento-barbital have been used to anesthetize   
trapped black bear (Ursus americanus)(Erickson, 1957). 
Gaseous Anesthetics - Ether and Chloroform
Effective use of gaseous anesthetics can only be achieved when they are administered in a   
closed environment.  Black bear caught in a culvert-type trap have been anesthetized by applying 
ether to the confines of the trap.  Bear caught in steel traps have been anesthetized by 
administering ether through a cone placed over the muzzle (Erickson, 1957)-Black et al. (1959)   
have used chloroform to anesthetize black bear. 
Ether has a curare-like action at the neuromuscular junction and can potentiate 
neuromuscular blocking agents.  Marked salivation occurs during the induction and recovery phases 
of ether anesthesia. 
Xylazine
Xylazine, first synthesized in 1962, produces sedation, analgesia, and muscular relaxation   
(Chemagro Corporation, 1970).  Bauditz (1972) has made a comprehensive review on the use of 
xylazine in captive and free-ranging wild animals.  In the majority of mammals, xylazine has   
pronounced sedative and muscle relaxant properties, accompanied by good analgesia and   
immobilization, with minimal excitement.  Xylazine has at least an 8-fold safety margin in 
captive white-tailed deer (Roughton, 1975).  His data also indicate that highly stressed deer are 
more quickly immobilized than unstressed deer.  With intramuscular doses ranging from 0.89 to 8.0   
mg/kg, induction times ranged from 1 to 22.5 minutes. Immobilization times ranged from 22 to 466 
minutes. Only transitory, minimal side effects such as increased heart rate and panting were 
noted.  Regurgitation did not occur. 
The Arylcycloalkylamines
The better known chemicals in this class are phencyclidine, ketamine, tiletamine, and CI-744   
(a mixture of tiletamine and zolazepam).  These chemical analogs produce a cateleptoid condition   
in animals characterized by "waxy rigidity" of the muscles so that animals tend to remain in   
any position in which they are placed.  They also produce marked analgesic and anesthetic effects 
without the loss of protective reflexes such as coughing and swallowing.  Some side effects of 
these chemicals include salivation, hyperthermia, excitement, and convulsions.  The use of these 
chemicals, complete with dosage charts, for several animal species has been reviewed by Beck 
(1972). 
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Phencyclidine
Gross behavior of animals given phencyclidine varies considerably among species.  Mice and 
rats exhibit excitatory symptoms.  In dogs, cats, and monkeys, sedation is evident at lower 
doses, while convulsions may be precipitated at higher doses (Domino, 1964). The majority of 
the common adverse effects (hypertonicity of the muscles, hyperthermia, salivation) of 
phencyclidine can be successfully eliminated by combination with other CNS depressants. 
The benefits of phencyclidine combined with promazine have been reported in a number of 
species of animals (Seal and Erickson, 1969). Harthoorn (1962, 1963) has used phencyclidine in 
combination with morphine or diethy1thiambutene, and hyoscine (scopolamine). This combination 
produced a large increase in the margin of safety and better immobilization characteristics in 
elephant, rhinoceros, hippopotamus, giraffe, and buffalo. 
Ketamine 
Ketamine differs from phencyclidine in that it is weaker in potency (amount of chemical 
to obtain a desired effect), has a faster onset and shorter duration of action, and a lower 
incidence of convulsant activity (Chen et al., 1966). 
Tiletamine
In general, the potency, onset and duration of action, and convulsant activity of 
tiletamine is intermediate between that of phencyclidine and ketamine.  Like phencyclidine, it 
produces good anesthesia in primates and the domestic cat (Chen et_ al_., 1969). 
 
CI-744 
 
CI-744 is the code number of a compound that contains a 1:1 combination of tiletamine 
hydrochloride and zolazepam. Tiletamine is classified as a cataleptoid anesthetic with marked 
central nervous system depressant properties. When used by itself, tiletamine produces a high   
incidence of convulsions in cats and dogs. However, zolazepam has anticonvulsant and 
antianxiety properties and when used in conjunction with tiletamine, convulsions are 
eliminated.  In fact, the two chemicals potentiate one another and the resultant effect is 
better muscle relaxation and anesthesia (Parke-Davis and Company, 1974). 
The Dithienylalkenylamines
Several chemicals in this class which have analgesic potencies comparable to that of 
morphine have been synthesized (Adamson, 1950). 
Thiambutene 
In dogs, thiambutene produces mild sedation, analgesia, and narcosis (Owen, 1955)-
Nalorphine is an effective antidote.  Thiambutene has had only limited application in 
capturing wild animals because of the large amount required to be effective and slow onset of 
action.  A combination of thiambutene, phencyclidine, and scopolamine has been used in four 
topi (Damaliscus korrigum) and two hippopotami (Hippopotamus amphibus).  Usually it required 
at least 30 minutes for the animals to become immobilized. (Royal Veterinary College of East 
Africa Expedition, 1963). 
Morphine and Its Derivatives
The immobilizing characteristics of these chemicals include stupor or insensibility, loss 
of fear and anxiety, and marked analgesia.  Frequently, animals stand with heads drooped, and 
if they fall to the ground they lie in sternal recumbency. These chemicals have a wide safety 
margin and severe side effects are minimal.  Effective antagonists are available which quickly 
reverse the immobilization effects.  Overdoses produce respiratory depression which is the 
cause of death. 
Morphine
Morphine is a natural chemical obtained from opium, which is the dried juice of the 
poppy plant, Papaver somniferum.  The chemical structure of morphine was established in 1925 
and since that time many derivatives have been synthesized.  By itself, morphine has been used 
to only a l i m i t e d  extent.  It is more effective when used in conjunction with 
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other chemicals, such as phencyclidine.  Morphine potentiates the analgesic activity of 
phencyclidine and renders an animal more tractable.  Effective immobilization of an 
animal by morphine and phencyclidine can be partially antagonized by administering 
nalorphine (Harthoorn, 1962; 1963). 
M99-Etorphine
Several morphine derivatives with analgesic activities ranging up to 10,000 times greater   
than morphine have been described by Bentley and Hardy (1963); and Bentley et al. (1965).     
One of these chemicals, etorphine, has been used extensively for capturing animals (Harthoorn 
and Bligh, 1965; Wallach, 1966; Woolf, 1970; Al ford et al., 1974; Roussel and Patenaude, 
1975).  The effective immobilization potency of etorphine is reported to be about 1,000 times 
that of morphine (Harthoorn, 1966).  Underdoses of etorphine are more stressful to animals than 
overdoses because they cause hyperexcitabi1ity and struggling. Promazine has been used to 
reduce the struggling in white-tailed deer, but the combination of etorphine with other CNS 
depressants is generally not considered necessary (Woolf, 1970; Alford et al., 1974.) 
Nalorphine, cyprenorphine (M285), and diprenorphine (M50-50) are effective antidotes to 
the narcotic effects of etorphine.  Diprenorphine is the most potent of the three and results   
in less residual central nervous system depression (King and Klingel, 1965; Alford et al., 
1974). 
The  Phenothiazines 
When used alone, phenothiazine derivatives such as chlorpromazine, promazine, and 
acetylpromazine are not effective immobi1izing agents because they have a slow onset of action 
and prolonged recovery periods.  They are best used in combination with other CNS depressants   
to produce potentiation of more desirable immobilizing characteristics. They are effective 
sedatives and can be used to transport animals.  These phenothiazines do not have analgesic 
properties.  Hypotension and hypothermia are common side effects. 
The Benzodiazepines
These chemicals can produce a "taming" effect in animals, but like the phenothiazines, 
they have limited application and are usually combined with other CNS depressants to achieve 
desirable immobilization characteristics.  As already stated, zolazepam is combined with 
tiletamine to reduce the incidence of convulsions in cats and dogs. 
In feeding studies with penned cowbirds (Molothrus ater) and coturnix quail (Coturnix 
coturnix), chlordiazepoxide was somewhat more effective than sodium pentobarbital in producing 
narcosis (Peek, 1966). Diazepam incorporated into a tab and fastened to jaws of a steel trap,   
produces sedation in trapped animals when they chew the tab.  Foot damage is reduced and 
animals can be removed from the trap more easily (Balser, 1965). 
Miscellaneous CNS Agents
Tribromoethanol and Alpha-chloralose
Tribromoethanol is a hypnotic drug that produces anesthesia. It has been used for the 
capture of wild turkeys (Meleagris gallopava) (Evans et al., 1975). Successful capture ranged   
from 50% to 92% with a mortality rate of 0% to 22% for the dosages employed.  Alpha-chloralose   
is another hypnotic drug which can produce long periods of anesthesia.  It has also been used 
for the capture of wild turkeys (Williams, 1966) and Canada geese (Branta canadensis) (Crider 
and McDaniel, 1967). 
Atropine and Scopolamine
Both atropine and scopolamine are anticholinergic drugs and are used frequently to 
antagonize side effects of salivation and cardiovascular disturbances such as decreased 
heart rate and low blood pressure.  Scopolamine has a more sedative effect than atropine. 
Combination of scopolamine with a morphine narcotic produces less respiratory depression 
than does the morphine narcotic by itself.                            
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SUMMARY 
Several major advances have been made in the use of chemicals for the capture of wildlife.     
These include mechanical improvements in delivery systems such as the projectile syringe 
(Crockford et. al., 1958), and the development of potent, relatively safe chemicals that can be 
used in a variety of species.  From the time when only a few neuromuscular blocking agents were 
of practical use, many central nervous system drugs have come into widespread application.  The 
centrally acting drugs are the chemicals of choice in most situations.  Mortality rates from the 
use of neuromuscular blocking agents range from 10 to 20% whereas the mortality rate with the 
centrally acting drugs is less than 3%. 
Many of the CNS drugs are regulated by the Drug Enforcement Administration (DEA), U.S. 
Department of Justice, and investigators are required by law to have a DEA registration number   
for their possession.  Authorization and clearance from the Food and Drug Administration, U.S.   
Department of Health, Education, and Welfare is highly recommended for the use of any drug,   
especially if the target animal is likely to become a source of food for humans. 
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